Overview

Relapse Prevention Study in Patients With Schizophrenia

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Iloperidone is effective in the prevention of relapse in patients with schizophrenia
Phase:
Phase 3
Details
Lead Sponsor:
Vanda Pharmaceuticals
Treatments:
Iloperidone